Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed

Pemetrexed (ALIMTA, LY231514, MTA) is a novel multitargeted antifolate that is currently approved for the treatment of metastatic nonsmall cell lung cancer (NSCLC). Recent evidence reveals that the drug’s efficacy is limited to nonsquamous lung cancer histology. As we further understand the drug’s m...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Steven F, Dudek, Arkadiusz Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513199/
https://www.ncbi.nlm.nih.gov/pubmed/23226032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513199/
https://www.ncbi.nlm.nih.gov/pubmed/23226032

Ejemplares similares